{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:55:46Z","timestamp":1760014546010,"version":"3.41.2"},"reference-count":25,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Res &amp; Perspec"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>It is common for patients with mental illnesses to be prescribed multiple psychotropic medications to effectively manage their conditions. Psychotropic polypharmacy has been shown to potentiate and increase the risks of several adverse effects, including QT prolongation. This study aimed to investigate the prescribing trends of and differences in prescribing of QT\u2010prolonging medications (QTPMs) at admission and discharge in hospitalized patients. This retrospective observational study utilized inpatient data from three public hospitals between January and December 2019. QTPMs were classified according to the AZCERT classification. QTPMs doses were evaluated by calculating the ratio of prescribed daily dose (PDD) to the defined daily dose (DDD). Subgroup analyses showed significant differences between patient groups on admission and discharge (all <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Mean QTPMs decreased significantly between the two time points only in patients admitted to acute medical and geriatric units (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). PDD\/DDD ratio for conditional risk QTPMs in acute mental health unit (AMHU) patients was increased at discharge (<jats:italic>p<\/jats:italic>\u2009=\u20090.038). Patients admitted to acute medical and geriatric units were four and eight times more likely to be discharged with one QTPM with known risk in combination with more QTPMs with conditional risk. Logistic regression showed significant relationships with age and total number of regular medicines at admission for those prescribed high\u2010dose QTPMs at discharge. The findings underscore the necessity for enhanced monitoring of QTPMs in hospitalized patients, particularly for those at higher risk.<\/jats:p>","DOI":"10.1002\/prp2.70107","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T05:20:04Z","timestamp":1745990404000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Psychotropic Polypharmacy and QT Prolonging Medications in Hospitalized Patients"],"prefix":"10.1002","volume":"13","author":[{"given":"Joel","family":"Moore","sequence":"first","affiliation":[{"name":"UniSA Clinical and Health Sciences University of South Australia  Adelaide South Australia Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"Singh","sequence":"additional","affiliation":[{"name":"UniSA Clinical and Health Sciences University of South Australia  Adelaide South Australia Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruby Tszwai","family":"Au","sequence":"additional","affiliation":[{"name":"UniSA Clinical and Health Sciences University of South Australia  Adelaide South Australia Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genevieve","family":"Gabb","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine Flinders Medical Centre  Bedford Park South Australia Australia"},{"name":"College of Medicine &amp; Public Health, Flinders University of South Australia  Bedford Park South Australia Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Eng\u2010Frost","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine Flinders Medical Centre  Bedford Park South Australia Australia"},{"name":"College of Medicine &amp; Public Health, Flinders University of South Australia  Bedford Park South Australia Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Hotham","sequence":"additional","affiliation":[{"name":"UniSA Clinical and Health Sciences University of South Australia  Adelaide South Australia Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sepehr","family":"Shakib","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology The Royal Adelaide Hospital  Adelaide South Australia Australia"},{"name":"Discipline of Pharmacology School of Medicine, University of Adelaide  Adelaide South Australia Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5496-935X","authenticated-orcid":false,"given":"Vijayaprakash","family":"Suppiah","sequence":"additional","affiliation":[{"name":"UniSA Clinical and Health Sciences University of South Australia  Adelaide South Australia Australia"},{"name":"Australian Centre for Precision Health, University of South Australia  Adelaide South Australia Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913\u2010018\u20103579\u20107"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5310"},{"key":"e_1_2_10_4_1","unstructured":"Therapeutic Guidelines Psychotropic Expert Group \u201cPsychotropic \u201d2021 https:\/\/www.tg.org.au."},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2015.110"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjsm.2008.054734"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.84.3.1136"},{"key":"e_1_2_10_8_1","unstructured":"CredibleMeds \u201cRisk Categories for Drugs That Prolong QT & induce Torsades de Pointes (TdP) \u201d2022 https:\/\/www.crediblemeds.org\/index.php\/druglist."},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1177\/2045125317721662"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2024.02.014"},{"key":"e_1_2_10_11_1","unstructured":"WHO \u201cATC\/DDD Index 2022 \u201d2022Norwegian Institute of Public Health https:\/\/www.whocc.no\/atc_ddd_index\/."},{"volume-title":"Australian Medicines Handbook: AMH","year":"2024","author":"AMH","key":"e_1_2_10_12_1"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-99138-4.00001-1"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149984"},{"volume-title":"The Third Australian Atlas of Healthcare Variation","year":"2018","author":"Australian Commission on Safety and Quality in Health Care","key":"e_1_2_10_15_1"},{"key":"e_1_2_10_16_1","unstructured":"S. G.Hilmer D.Gnjidic E.Reeve et\u00a0al. \u201cUse of Antipsychotic Medicines for People Aged 65\u2009Years and Over: A Literature Review \u201d(ACSQHC 2020)."},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1177\/17539447211058892"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2018.07.002"},{"key":"e_1_2_10_19_1","unstructured":"K.BaxterandC.Preston \u201cStockley's Drug Interactions \u201d2023 https:\/\/www.new.medicinescomplete.com\/#\/interactions\/stockley."},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/s42444\u2010022\u201000065\u2010z"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1023\/a:1024122706337"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmra032426"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.01.001"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2013.12060860"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1161\/circoutcomes.113.000152"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096\u2010017\u20100446\u20102"}],"container-title":["Pharmacology Research &amp; Perspectives"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/prp2.70107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T10:19:56Z","timestamp":1750155596000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1002\/prp2.70107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1002\/prp2.70107"],"URL":"https:\/\/doi.org\/10.1002\/prp2.70107","archive":["Portico"],"relation":{},"ISSN":["2052-1707","2052-1707"],"issn-type":[{"type":"print","value":"2052-1707"},{"type":"electronic","value":"2052-1707"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"2024-11-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70107"}}